Content Stream

One Member Finds a Lifeline While Managing Severe Asthma

For Andrew, breathing is a daily, ongoing struggle. Andrew was first diagnosed with moderate asthma when he was 10 years old. His first trip to the emergency room due to an asthma attack would be the first of many all-too-familiar trips. Through high school, asthma didn’t just affect him physically, but emotionally and academically, too. In addition to working hard to keep up with classwork from missed days, he also had to face relentless bullying – so severe that he had to change schools to...

Omalizumab Makes Oral Immunotherapy Treatments More Effective

Combining a 16-week initial course of the medication omalizumab with oral immunotherapy (OIT) greatly improves the efficacy of OIT for children with allergies to multiple foods, new clinical trial findings show. After 36 weeks, more than 80 percent of children who received omalizumab and OIT could safely consume two-gram portions of at least two foods to which they were allergic, compared with only a third of children who received placebo and OIT.

×
×
×
×